Cancer, Advanced Not Yet Recruiting Phase 3 Trials for Endostatin (DB06423)

Also known as: Advanced Cancer / Cancer / Neoplasm malignant / Malignant neoplasm NOS / Cancer NOS / Malignant tumor / Malignant tumour / Cancer (NOS) / Malignant neoplasm without specification of site

DBCOND0041606 (Cancer, Advanced)Not Yet Recruiting3 IdentifierTitlePurposeDrugs
NCT03008109Endostar Plus EGFR-TKI(Epidermal Growth Factor Receptor—Tyrosine-Kinase Inhibitor) as a Treatment of EGFR Mutation-positive NSCLCTreatment